Siplizumab
Product Specifications
CAS Number
288392-69-8
Target
Immunology/Inflammation related, Others
Related Pathways
Immunology/Inflammation, Others
Purity
1
Bioactivity
Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog